Literature DB >> 24935633

Downregulation of Notch modulators, tetraspanin 5 and 10, inhibits osteoclastogenesis in vitro.

Jian Zhou1,2, Toshifumi Fujiwara2, Shiqiao Ye2, Xiaolin Li1, Haibo Zhao2.   

Abstract

Genetic studies in human and mice have pinpointed an essential role of Notch signaling in osteoblast and osteoclast differentiation during skeletal development and bone remodeling. However, the factors and pathways regulating Notch activation in bone cells remain largely unknown. In this in vitro study, we have provided evidence that two of the TspanC8 subfamily members of tetraspanins, Tspan-5 and Tspan-10, are up-regulated during osteoclast differentiation and knockdown of their expression by shRNAs dramatically inhibits osteoclastogenesis. Loss of Tspan-5 and Tspan-10 in osteoclast lineage cells results in attenuation of ADAM10 maturation and Notch activation. Therefore, these two tetraspanins play a critical role in osteoclast formation, at least in part, by modulating Notch signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24935633      PMCID: PMC4139439          DOI: 10.1007/s00223-014-9883-2

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  34 in total

1.  Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.

Authors:  S Takeshita; K Kaji; A Kudo
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

Review 2.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

Review 3.  Genetic regulation of osteoclast development and function.

Authors:  Steven L Teitelbaum; F Patrick Ross
Journal:  Nat Rev Genet       Date:  2003-08       Impact factor: 53.242

Review 4.  Tetraspanin functions and associated microdomains.

Authors:  Martin E Hemler
Journal:  Nat Rev Mol Cell Biol       Date:  2005-10       Impact factor: 94.444

5.  RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis.

Authors:  Masaru Ishii; Kaori Iwai; Masato Koike; Shiro Ohshima; Eriko Kudo-Tanaka; Taeko Ishii; Toru Mima; Yoshinori Katada; Kunio Miyatake; Yasuo Uchiyama; Yukihiko Saeki
Journal:  J Bone Miner Res       Date:  2006-06       Impact factor: 6.741

Review 6.  Tetraspanin proteins promote multiple cancer stages.

Authors:  Martin E Hemler
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

7.  Increased osteoclast development after estrogen loss: mediation by interleukin-6.

Authors:  R L Jilka; G Hangoc; G Girasole; G Passeri; D C Williams; J S Abrams; B Boyce; H Broxmeyer; S C Manolagas
Journal:  Science       Date:  1992-07-03       Impact factor: 47.728

Review 8.  Osteopetrosis and osteoporosis: two sides of the same coin.

Authors:  F Lazner; M Gowen; D Pavasovic; I Kola
Journal:  Hum Mol Genet       Date:  1999       Impact factor: 6.150

9.  ADAM gene expression and regulation during human osteoclast formation.

Authors:  S Verrier; A Hogan; N McKie; M Horton
Journal:  Bone       Date:  2004-07       Impact factor: 4.398

10.  Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.

Authors:  Yoshito Takeda; Isao Tachibana; Kenji Miyado; Masatoshi Kobayashi; Toru Miyazaki; Toshiki Funakoshi; Hiromi Kimura; Hiroyuki Yamane; Yoshiyuki Saito; Hiroyuki Goto; Tsutomu Yoneda; Mitsuhiro Yoshida; Toru Kumagai; Tadashi Osaki; Seiji Hayashi; Ichiro Kawase; Eisuke Mekada
Journal:  J Cell Biol       Date:  2003-06-09       Impact factor: 10.539

View more
  24 in total

1.  Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.

Authors:  Héctor F Araya; Hugo Sepulveda; Carlos O Lizama; Oscar A Vega; Sofia Jerez; Pedro F Briceño; Roman Thaler; Scott M Riester; Marcelo Antonelli; Flavio Salazar-Onfray; Juan Pablo Rodríguez; Ricardo D Moreno; Martin Montecino; Martine Charbonneau; Claire M Dubois; Gary S Stein; Andre J van Wijnen; Mario A Galindo
Journal:  J Cell Biochem       Date:  2018-06-19       Impact factor: 4.429

2.  Ubiquitin E3 Ligase LNX2 is Critical for Osteoclastogenesis In Vitro by Regulating M-CSF/RANKL Signaling and Notch2.

Authors:  Jian Zhou; Toshifumi Fujiwara; Shiqiao Ye; Xiaolin Li; Haibo Zhao
Journal:  Calcif Tissue Int       Date:  2015-02-25       Impact factor: 4.333

3.  Tetraspanin-5-mediated MHC class I clustering is required for optimal CD8 T cell activation.

Authors:  Jeff D Colbert; Freidrich M Cruz; Christina E Baer; Kenneth L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  2022-10-10       Impact factor: 12.779

4.  Notch signaling promotes osteoclast maturation and resorptive activity.

Authors:  Jason W Ashley; Jaimo Ahn; Kurt D Hankenson
Journal:  J Cell Biochem       Date:  2015-11       Impact factor: 4.429

5.  The tetraspanin Tspan15 is an essential subunit of an ADAM10 scissor complex.

Authors:  Chek Ziu Koo; Neale Harrison; Peter J Noy; Justyna Szyroka; Alexandra L Matthews; Hung-En Hsia; Stephan A Müller; Johanna Tüshaus; Joelle Goulding; Katie Willis; Clara Apicella; Bethany Cragoe; Edward Davis; Murat Keles; Antonia Malinova; Thomas A McFarlane; Philip R Morrison; Hanh T H Nguyen; Michael C Sykes; Haroon Ahmed; Alessandro Di Maio; Lisa Seipold; Paul Saftig; Eleanor Cull; Christos Pliotas; Eric Rubinstein; Natalie S Poulter; Stephen J Briddon; Nicholas D Holliday; Stefan F Lichtenthaler; Michael G Tomlinson
Journal:  J Biol Chem       Date:  2020-02-28       Impact factor: 5.157

6.  Novel Role for Claudin-11 in the Regulation of Osteoblasts via Modulation of ADAM10-Mediated Notch Signaling.

Authors:  Richard C Lindsey; Weirong Xing; Sheila Pourteymoor; Catrina Godwin; Alexander Gow; Subburaman Mohan
Journal:  J Bone Miner Res       Date:  2019-07-26       Impact factor: 6.390

Review 7.  Regulation of ADAM10 by the TspanC8 Family of Tetraspanins and Their Therapeutic Potential.

Authors:  Neale Harrison; Chek Ziu Koo; Michael G Tomlinson
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

8.  TspanC8 Tetraspanins and A Disintegrin and Metalloprotease 10 (ADAM10) Interact via Their Extracellular Regions: EVIDENCE FOR DISTINCT BINDING MECHANISMS FOR DIFFERENT TspanC8 PROTEINS.

Authors:  Peter J Noy; Jing Yang; Jasmeet S Reyat; Alexandra L Matthews; Alice E Charlton; Joanna Furmston; David A Rogers; G Ed Rainger; Michael G Tomlinson
Journal:  J Biol Chem       Date:  2015-12-14       Impact factor: 5.157

9.  TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.

Authors:  M Gupta; D Neavin; D Liu; J Biernacka; D Hall-Flavin; W V Bobo; M A Frye; M Skime; G D Jenkins; A Batzler; K Kalari; W Matson; S S Bhasin; H Zhu; T Mushiroda; Y Nakamura; M Kubo; L Wang; R Kaddurah-Daouk; R M Weinshilboum
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

10.  RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival.

Authors:  T Fujiwara; J Zhou; S Ye; H Zhao
Journal:  Cell Death Dis       Date:  2016-07-21       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.